{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/psoriasis/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"58b4da96-dda6-596b-9570-fd5070898cfe","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 8a14044e-343d-4121-9c37-2f9249b56d4e --><h2>How should I classify psoriasis?</h2><!-- end field 8a14044e-343d-4121-9c37-2f9249b56d4e -->","summary":"","htmlStringContent":"<!-- begin item 13c683db-7e36-4f5c-bc13-e8e0b4217060 --><!-- begin field 5cd52f96-0ed8-4bf4-b2a6-ed028ef75edb --><ul><li><strong><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/assessment/\">Assess</a> a person with suspected psoriasis to classify the type of psoriasis, where possible, depending on the site of involvement and associated clinical features:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#pustular-psoriasis\">Pustular psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#erythrodermic-psoriasis\">Erythrodermic psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#chronic-plaque-psoriasis\">Chronic plaque psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#scalp-psoriasis\">Scalp psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#facial-psoriasis\">Facial psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#flexural-psoriasis\">Flexural psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#guttate-psoriasis\">Guttate psoriasis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#nail-psoriasis\">Nail psoriasis</a>.</li></ul></li></ul><!-- end field 5cd52f96-0ed8-4bf4-b2a6-ed028ef75edb --><!-- end item 13c683db-7e36-4f5c-bc13-e8e0b4217060 -->","topic":{"id":"a3ecec3a-acde-5ece-90b0-dedc6c08db8b","topicId":"c8702cb0-6f30-44e4-832b-ab9161ee384a","topicName":"Psoriasis","slug":"psoriasis","lastRevised":"Last revised in December 2020","chapters":[{"id":"d0c39045-d8df-5a7e-bd7d-96fef3aefc3a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6e22adaa-de33-5d1c-bc1f-9740d238c5a2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a7c9da10-9760-5143-bf20-167f1e832103","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"409aaeee-7f7b-53cc-afdc-9ea9034984d6","slug":"changes","fullItemName":"Changes"},{"id":"1677a6dc-645a-58fe-8ed8-8bdfcface768","slug":"update","fullItemName":"Update"}]},{"id":"ca38cddf-4680-5dc4-a0df-79ab9910a789","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fc350387-9e56-5f4b-b454-3cfa5ecd9a2a","slug":"goals","fullItemName":"Goals"},{"id":"00a9f2b3-e7b5-5394-9762-48d34a0dc722","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"400cbb71-cb76-5ee3-824a-738bc6249b3b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ad046045-038c-5b75-8f42-50343d5b824e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"773d3740-99b6-5a32-b555-968b2efb0b8b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0692cf2f-4b3d-5098-afe3-ac07b3c763ff","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d16fcd88-1021-5238-86e4-2452eee7fdde","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ef476810-392e-5b83-b527-fe921221cc0b","slug":"definition","fullItemName":"Definition"},{"id":"fb1e0af3-fd46-562a-83d6-33a31640b639","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d6b8dab4-762f-5e9e-a83e-35a3652483b3","slug":"trigger-factors","fullItemName":"Trigger factors"},{"id":"70837c8d-73ae-5bc4-a042-949d31503ca3","slug":"associated-conditions","fullItemName":"Associated conditions"},{"id":"e90f3736-0e28-53fa-8295-309df8aa8e00","slug":"complications","fullItemName":"Complications"},{"id":"9523ad16-6e73-50ba-94bd-64c548f5c313","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4d0deda5-f89f-59e7-8978-1c3337afdcfe","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"067d150c-d6d4-5992-9319-f86bfeecca88","slug":"assessment","fullItemName":"Assessment"},{"id":"58b4da96-dda6-596b-9570-fd5070898cfe","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"27af05e5-54bf-5bc5-ba76-d1b8f18e7252","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eaab9e94-c74e-5c84-ba14-d8db3a6dd1e8","fullItemName":"Management","slug":"management","subChapters":[{"id":"82ee7501-0589-54c2-8df7-5a9256a3f1d0","slug":"pustular-or-erythrodermic-psoriasis","fullItemName":"Scenario: Pustular or erythrodermic psoriasis"},{"id":"e4183760-c129-567e-9211-cef27ef68100","slug":"trunk-limbs","fullItemName":"Scenario: Trunk and limbs"},{"id":"6a7e9d56-0d17-5c90-b835-822367fbcd3e","slug":"scalp-psoriasis","fullItemName":"Scenario: Scalp psoriasis"},{"id":"9c7cebad-a77f-5fa8-811a-50815577a51c","slug":"facial-flexural/genital-psoriasis","fullItemName":"Scenario: Facial/flexural/genital psoriasis"},{"id":"6fbadcef-730e-5874-97ad-53e1f12bd5e3","slug":"guttate-psoriasis","fullItemName":"Scenario: Guttate psoriasis"},{"id":"a069495e-d2fe-5fca-9799-1b5f4f874033","slug":"nail-psoriasis","fullItemName":"Scenario: Nail psoriasis"},{"id":"08dc9427-b5ec-59f4-b47b-72a666beacef","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"ce3be64b-a968-59e2-b206-5a055de98330","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"520d3bb6-49cf-5f46-b761-9df1c712ad28","slug":"emollients","fullItemName":"Emollients"},{"id":"2a68bcd1-b92f-579a-955e-f4638d00073f","slug":"vitamin-d-preparations","fullItemName":"Vitamin D preparations"},{"id":"39f1a594-6e44-59b9-bb85-a277475d7386","slug":"salicylic-acid","fullItemName":"Salicylic acid"},{"id":"325d4c77-192a-5152-971f-a5f4f1d64fc7","slug":"coal-tar-products","fullItemName":"Coal tar products"},{"id":"302b90f5-e0d6-53cc-88ce-6a06def02b51","slug":"dithranol-short-contact","fullItemName":"Dithranol (short-contact)"}]},{"id":"00678b76-cc05-5d69-a6be-8760727fb9cf","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"91ae130b-06c7-538c-a295-af4bf7a3dbf1","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"358d84df-224b-5d6b-96cd-c52dfe00a200","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"383c93f2-ae1f-5c75-af43-3a9a448c1669","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3703e9fb-0103-5fe6-a0ed-192226578ed6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d248a57f-2b73-5c2f-89c5-18ed618c3535","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e35fcef8-37a3-5afe-9250-f527d2c6e017","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7314bc52-4cb9-530c-a905-917edad0de05","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4d0deda5-f89f-59e7-8978-1c3337afdcfe","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"50f8c382-0e0f-52d0-a10b-2b65f87a1bfa","slug":"pustular-psoriasis","fullItemName":"Pustular psoriasis","depth":3,"htmlHeader":"<!-- begin field c3464dec-d6a0-45b6-b5b1-a75900e57736 --><h3>Pustular psoriasis</h3><!-- end field c3464dec-d6a0-45b6-b5b1-a75900e57736 -->","summary":null,"htmlStringContent":"<!-- begin item 85c81364-20ec-4bcb-8b53-a75900e577ba --><!-- begin field 382227b4-ac6c-4086-a57b-a75900e57736 --><p><strong>Pustular psoriasis may be generalized or localized.</strong></p><ul><li>Generalized pustular psoriasis (a potentially life-threatening <a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/management/pustular-or-erythrodermic-psoriasis/#management\">medical emergency</a>)<ul><li>Rapidly developing widespread erythema, followed by the eruption of white, sterile non-follicular pustules which coalesce to form large lakes of pus.</li><li>Lesions associated with systemic illness, such as fever, malaise, tachycardia, weight loss, and arthralgia.</li><li>Usually presents in people with existing or previous chronic plaque psoriasis, but can also occur in people without a history of psoriasis.</li></ul></li><li>Localized (palmoplantar) pustular psoriasis<ul><li>Lesions on the palms and soles, such as yellow-brown pustules within established psoriasis plaques, or redness, scaling, and pustules at the tips of the fingers and toes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">SIGN, 2010a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field 382227b4-ac6c-4086-a57b-a75900e57736 --><!-- end item 85c81364-20ec-4bcb-8b53-a75900e577ba -->","subChapters":[]},{"id":"b48adda4-b363-58d0-a232-387979d45641","slug":"erythrodermic-psoriasis","fullItemName":"Erythrodermic psoriasis","depth":3,"htmlHeader":"<!-- begin field 783eb246-1e0f-4f58-8be2-a75900e5978e --><h3>Erythrodermic psoriasis</h3><!-- end field 783eb246-1e0f-4f58-8be2-a75900e5978e -->","summary":null,"htmlStringContent":"<!-- begin item 3df7f8bc-cc2e-4cf4-8833-a75900e597c2 --><!-- begin field 10e91ffa-31b8-453a-8d3f-a75900e5978e --><p><strong>Erythrodermic psoriasis is a potentially life-threatening <a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/management/pustular-or-erythrodermic-psoriasis/#management\">medical emergency</a>.</strong></p><ul><li>Diffuse, widespread severe psoriasis that affects more than 90% of the body surface area [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Cohen, 2012</a>].<ul><li>It can develop gradually from chronic plaque psoriasis or appear abruptly, even in people with mild psoriasis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Weigle, 2013</a>].</li><li>It can be precipitated by various factors such as systemic infection; irritants such as coal tar or ciclosporin; phototherapy; or sudden withdrawal of corticosteroids [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Myers et al, 2006</a>].</li></ul></li><li>Lesions may feel warm, and may be associated with systemic illness, such as fever, malaise, tachycardia, lymphadenopathy, and peripheral oedema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Meier and Sheth, 2009</a>].</li></ul><!-- end field 10e91ffa-31b8-453a-8d3f-a75900e5978e --><!-- end item 3df7f8bc-cc2e-4cf4-8833-a75900e597c2 -->","subChapters":[]},{"id":"9fc9ba92-96f4-575e-b84e-c1c3ca73fcd5","slug":"chronic-plaque-psoriasis","fullItemName":"Chronic plaque psoriasis","depth":3,"htmlHeader":"<!-- begin field 09a9cadc-a288-44da-92b7-a75900e51803 --><h3>Chronic plaque psoriasis</h3><!-- end field 09a9cadc-a288-44da-92b7-a75900e51803 -->","summary":null,"htmlStringContent":"<!-- begin item b7a4c1f2-8bfd-443b-8d5c-a75900e51852 --><!-- begin field 442a0f68-7248-4d5c-a665-a75900e51803 --><p><strong>Chronic plaque psoriasis typically presents as:</strong></p><ul><li>Monomorphic, erythematous plaques covered by adherent silvery-white scale, usually on the scalp, behind the ears, trunk, buttocks, periumbilical area, and extensor surfaces (such as forearms, shins, elbows, and knees).</li><li>Lesions which are typically distributed symmetrically and can coalesce to form larger lesions.<ul><li>On white skin, the plaques are pink or red; in deeply pigmented skin, plaques usually have a grey colour and may cause marked post-inflammatory hyperpigmentation.</li><li>Most lesions are 1 cm to several centimetres in diameter, with an oval or irregular shape.</li><li>There is usually a clear delineation between normal and affected skin.</li><li>Scale is usually present — it is usually silver-white in colour, but less commonly can be a waxy yellow or orange-brown. The thickness of the scale varies, but it can be very thick. If the scale is gently removed, a glossy red membrane with pinpoint bleeding points (Auspitz's sign) is revealed.</li><li>Occasionally, a halo-like effect is seen around a plaque, due to vasoconstriction (Woronoff's ring).</li><li>Fissures may form if the plaque is over a joint line or on the palm or sole.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">SIGN, 2010a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Cohen, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field 442a0f68-7248-4d5c-a665-a75900e51803 --><!-- end item b7a4c1f2-8bfd-443b-8d5c-a75900e51852 -->","subChapters":[]},{"id":"15d714fe-3ad3-5e92-8d6b-7b4bfbe95ed3","slug":"scalp-psoriasis","fullItemName":"Scalp psoriasis","depth":3,"htmlHeader":"<!-- begin field d9084889-9c5b-457f-87a9-a75900e52e83 --><h3>Scalp psoriasis</h3><!-- end field d9084889-9c5b-457f-87a9-a75900e52e83 -->","summary":null,"htmlStringContent":"<!-- begin item 3cd7bbe9-0396-43b5-963f-a75900e52e09 --><!-- begin field f1743565-0a0e-4b50-9621-a75900e52e83 --><p><strong>Scalp psoriasis affects 75–90% of people with psoriasis.</strong></p><ul><li>It typically presents as <a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#chronic-plaque-psoriasis\">chronic plaque psoriasis</a> affecting the scalp area.</li><li>The whole scalp can be affected, or individual plaques may be visible. Plaques may be very thick, particularly in the occipital region.</li><li>It may be associated with areas of non-scarring alopecia in some people, particularly if there is:<ul><li>Thick, adherent scale extending up the hair shaft (pityriasis amiantacea).</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#erythrodermic-psoriasis\">Erythrodermic psoriasis</a> — this can cause severe alopecia.</li><li>Repeated scratching of the scalp due to itch (usually reversible).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Griffiths et al, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field f1743565-0a0e-4b50-9621-a75900e52e83 --><!-- end item 3cd7bbe9-0396-43b5-963f-a75900e52e09 -->","subChapters":[]},{"id":"99aa87c2-d696-5008-890c-14f2a9d9187e","slug":"facial-psoriasis","fullItemName":"Facial psoriasis","depth":3,"htmlHeader":"<!-- begin field 71e1bfe6-884c-4e38-8402-a75900e5406d --><h3>Facial psoriasis</h3><!-- end field 71e1bfe6-884c-4e38-8402-a75900e5406d -->","summary":null,"htmlStringContent":"<!-- begin item 52fa5bd4-0ff4-4d70-9b45-a75900e54064 --><!-- begin field 806b866d-c563-4ad8-b697-a75900e5406d --><p><strong>Facial psoriasis typically presents as:</strong></p><ul><li>Well-demarcated plaques on the face, similar to those of chronic plaque psoriasis.</li><li>Lesions which may affect the hairline.</li><li>Possible mild scaling around the eyebrows and nasolabial folds, which may be due to co-existent seborrhoeic dermatitis (so-called 'sebo-psoriasis') — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> for more information.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">van de Kerkhof et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field 806b866d-c563-4ad8-b697-a75900e5406d --><!-- end item 52fa5bd4-0ff4-4d70-9b45-a75900e54064 -->","subChapters":[]},{"id":"e06aee60-6505-51b6-9f9e-a48b30d26e6d","slug":"flexural-psoriasis","fullItemName":"Flexural psoriasis","depth":3,"htmlHeader":"<!-- begin field 2cb24d05-0f9d-49f1-9ce6-a75900e557f7 --><h3>Flexural psoriasis</h3><!-- end field 2cb24d05-0f9d-49f1-9ce6-a75900e557f7 -->","summary":null,"htmlStringContent":"<!-- begin item a43eed22-d195-4194-a84b-a75900e5584d --><!-- begin field 109b69a9-851e-468e-a34e-a75900e557f7 --><p><strong>Flexural psoriasis typically presents as:</strong></p><ul><li>Itchy psoriasis lesions affecting areas such as the groin, genital area, axillae, inframammary folds, abdominal folds, sacral and gluteal cleft.<ul><li>The elderly, immobile, and people who are overweight or obese are at increased risk of being affected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Menter et al, 2008</a>].</li></ul></li><li>Lesions of <a class=\"topic-reference internal-reference\" href=\"/topics/psoriasis/diagnosis/diagnosis/#chronic-plaque-psoriasis\">chronic plaque psoriasis</a> which are well-defined, but there may be little or no scaling, due to friction and occlusion at these sites.<ul><li>Lesions are often red and glazed in appearance, and there may be a fissure in the skin crease.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Cohen, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field 109b69a9-851e-468e-a34e-a75900e557f7 --><!-- end item a43eed22-d195-4194-a84b-a75900e5584d -->","subChapters":[]},{"id":"934600ef-2ea8-5b73-aa11-a6a5d92c9f0c","slug":"guttate-psoriasis","fullItemName":"Guttate psoriasis","depth":3,"htmlHeader":"<!-- begin field 80019fe9-df8a-450b-8ce0-a75900e567d6 --><h3>Guttate psoriasis</h3><!-- end field 80019fe9-df8a-450b-8ce0-a75900e567d6 -->","summary":null,"htmlStringContent":"<!-- begin item 26906198-ccd9-404a-af6e-a75900e567a8 --><!-- begin field 061d7289-c781-466f-bf75-a75900e567d6 --><p><strong>Guttate psoriasis typically presents as:</strong></p><ul><li>Small, scattered, round or oval (2 mm to 1 cm in diameter) scaly papules, which may be pink or red.</li><li>Multiple lesions which may occur all over the body over a period of 1–7 days, particularly on the trunk and proximal limbs. Lesions may occur on the face, ears, and scalp, but rarely affect the soles of the feet.</li><li>A first presentation of psoriasis (classically after acute streptococcal upper respiratory tract infection), or as an acute exacerbation of plaque psoriasis.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">SIGN, 2010a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Young, 2017</a>] </p><!-- end field 061d7289-c781-466f-bf75-a75900e567d6 --><!-- end item 26906198-ccd9-404a-af6e-a75900e567a8 -->","subChapters":[]},{"id":"54c7816c-a476-5aff-870f-bd3dd6f35e0d","slug":"nail-psoriasis","fullItemName":"Nail psoriasis","depth":3,"htmlHeader":"<!-- begin field 0228ca41-a02b-4300-b5c4-a75900e5a680 --><h3>Nail psoriasis</h3><!-- end field 0228ca41-a02b-4300-b5c4-a75900e5a680 -->","summary":null,"htmlStringContent":"<!-- begin item 17130acc-ff2b-407c-b6f0-a75900e5a6ae --><!-- begin field 2163d7b8-019d-40ba-b909-a75900e5a680 --><p><strong>Nail psoriasis more commonly affects fingernails than toenails (50% and 35% respectively), and may affect all parts of the nail and surrounding structures.</strong></p><ul><li>Nail changes can occur with any type of psoriasis, and are particularly common in people with psoriatic arthritis (up to 90% of people are affected). The incidence of nail involvement increases with the duration of psoriasis.<ul><li>Nail pitting (depressions in the nail plate) is the most common finding.</li><li>Discolouration (for example the 'oil drop sign') — orange-yellow discolouration of the nail bed.</li><li>Subungual hyperkeratosis — hyperproliferation of the nail bed, with accumulation of keratinocytes under the nail.</li><li>Onycholysis — detachment of the nail from the nail bed, which may allow bacteria and fungi to enter and cause infection.</li><li>Complete nail dystrophy.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Cohen, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Weigle, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">de Vries, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Crowley, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/psoriasis/references/\">Boehncke, 2015</a>] </p><!-- end field 2163d7b8-019d-40ba-b909-a75900e5a680 --><!-- end item 17130acc-ff2b-407c-b6f0-a75900e5a6ae -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}